CD274 and neoplasm: The impact of using different PD-L1 clones is underlined by a recent study from the „Blueprint PD-L1 IHC Assay Comparison Project“, which demonstrated that the clones 28–8, 22C3 and SP263 show a similar proportion of positive tumor cells, whereas SP142 stains a lower proportion of tumor cells [10, 23].